Eric Lefebvre - 24 Jan 2024 Form 4 Insider Report for CymaBay Therapeutics, Inc.

Role
Director
Signature
/s/ Paul Quinlan, as attorney-in-fact for Eric Lefebvre
Issuer symbol
N/A
Transactions as of
24 Jan 2024
Net transactions value
$0
Form type
4
Filing time
26 Jan 2024, 18:16:29 UTC
Previous filing
24 Jan 2024
Next filing
22 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Stock Option (right to buy) Award $0 +14,010 $0.000000 14,010 24 Jan 2024 Common Stock 14,010 $22.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/12 of the underlying shares monthly from January 1, 2024.